Bengal Physician Journal

Register      Login

VOLUME 10 , ISSUE 2 ( May-August, 2023 ) > List of Articles


Immune Thrombocytopenic Purpura Secondary to Carcinoma Tongue: A Rare Case Presentation

Moumana Das, Rimi Som Sengupta, JM Jeetendra Kumar, Sagnic Mandal, Anirban Ghosh

Keywords : Carcinoma tongue, Case report, Immune thrombocytopenic purpura, Thrombocytopenia

Citation Information : Das M, Sengupta RS, Kumar JJ, Mandal S, Ghosh A. Immune Thrombocytopenic Purpura Secondary to Carcinoma Tongue: A Rare Case Presentation. Bengal Physician Journal 2023; 10 (2):71-72.

DOI: 10.5005/jp-journals-10070-8014

License: CC BY-NC 4.0

Published Online: 07-08-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Immune thrombocytopenic purpura (ITP) secondary to carcinoma tongue, is a relatively rare manifestation. An association of ITP with lymphoproliferative disorder comprises about 30% of cases of secondary ITP. A clinical correlation between ITP and carcinoma tongue was never reported before. Case description: A 48-year-old female with infiltrating squamous cell carcinoma tongue was admitted with isolated severe thrombocytopenia, without signs of active bleeding. She was treated conservatively and discharged. Then again after 15 days, she was readmitted with thrombocytopenia. Bone marrow examination showed megakaryocytic hyperplasia with normal morphology of erythroid and myeloid series with no evidence of infiltration of bone marrow by tumor cells. Finally, the diagnosis of ITP related to carcinoma tongue was reached. Conclusion: Immune thrombocytopenic purpura is mostly primary but it can occur secondary to autoimmune disorders, infections, such as HIV, Hepatitis C, H. pylori, lymphoid neoplasms and occasionally solid tumors. This patient is an example of ITP secondary to a solid tumor with a clinical course concomitant to the course of carcinoma tongue. This case supports the relationship between carcinoma tongue and the immune disease.

  1. Hugli S, Hugli A, Simonetta F, Chalandon Y. A rare case of immune thrombocytopenia secondary to breast cancer. Clin Case Rep 2019;7(1):170–174. DOI: 10.1002/ccr3.1939.
  2. Peffault de Latour R, Des Guetz G, Laurence V, et al. Breast cancer associated with idiopathic thrombocytopenic purpura. Am J Clin Oncol 2004;27(4):333–336. DOI: 10.1097/01.coc.0000071461.61445.9a.
  3. Visco C, Rodeghiero F. Immune thrombocytopenia in lymphoproliferative disorders. Hematol Oncol Clin N Am 2009;23:1261–1274. DOI: 10.1016/j.hoc.2009.08.006.
  4. Lambert MP, Gernsheimer TB, Clinical updates in adult immune thrombocytopenia. Blood J 2018;129(21):2829–2835. DOI: 10.1182/blood-2017-03-754119.
  5. Krauth MT, Puthenparambil J, Lechner K. Paraneoplastic autoimmune thrombocytopenia in solid tumors. Crit Rev Oncol Hematol 2012;81:75–81. DOI: 10.1016/j.critrevonc.2011.02.004.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.